Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
IDXXIdexx Laboratories
FinDog View：Neutral
| Metric | GILD | IDXX |
|---|
| Close | 147.68 | 513.62 |
| Market Cap | $183B | $40.5B |
| 1M | +6.31% | −5.95% |
| P/E (TTM) | — | 35.5 |
| Forward P/E | 25.3 | 35.6 |
| P/E 5-Yr Percentile | — | 0 |
| P/S | 6.0 | 8.9 |
| P/B | 15.3 | 25.1 |
| Dividend Yield | 3.98% | — |
| Latest Quarter Revenue | $7.8B | $1.2B |
| Revenue YoY | +10.2% | +9.7% |
| Gross Margin | 79.8% | 64.0% |
| Latest Quarter EPS | -8.45 | 4.27 |
| Avg Post-Earnings Move | ±3.8% | ±1.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.01% | 2.91% |
| 90-Day Net Insider Buying | −$15.4M | −$1.2M |
GILD · Revenue, Last 8 Quarters ($B)
IDXX · Revenue, Last 8 Quarters ($B)
